Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 276-344-2 | CAS number: 72102-84-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
There are no studies available in which the toxicokinetic properties of the test substance were investigated. Based on the large molecular size, the absence of adverse findings in toxicity studies, and the presence of functional groups for metabolism, a potential for bioaccumulation is unlikely. Further details for this assessments are given below.
Chemistry
The test substance (molecular weight of 302 Da) is an orange powder those water solubility (deionised water) is < 0.098 mg/L. The material decomposes at temperatures above 230 °C which excludes vaporisation of the test material. Examination of the particle size distribution revealed that most of the particles are 82.2 µm or larger, only 10 % are 2.4 µm or smaller. With regard to the molecular structure of the substance hydrolysis is not likely.
Absorption
In an acute oral and inhalation toxicity study, rats were administered to the test substance. No mortalities or clinical signs of toxicity were observed in doses of > 6000 mg/kg bw and 2119 mg/m3 air, respectively, indicating primarily a very low level of oral and inhalation toxicity. The NOAEL in male and female rats in a subacute oral repeated dose study is 300 and 1000 mg/kg bw, respectively, due to an increase in absolute and relative liver weight. In an OECD 421 screening study the NOAEL for parental animals and F1 animals is considered to be 1000 mg/kg bw. Effects on organ weights were not observed. Orange-discolored feces during the treatment period as well as orange discoloration of the gastro-intestinal tract was observed indicating very limited absorption of the substance via the oral route.
An additional sub-acute study was performed to determine the bioavailability of the test substance after oral administration at limit dose. Clinical examination revealed
orange discolored feces in all animals from study day 1 onwards. Orange discoloration of contents in the glandular stomach, jejunum and cecum was also observed. Trace amounts of the applied substance could be detected in liver, spleen and kidney tissue of individual animals ranging from 0.94 - 15.3 ng/mg tissue. No test item could be detected in rat plasma samples. Thus, it could be concluded that the test item was bioavailable in the absence of signs of toxicity.
In regard to the poor water solubility and the absence of hydrolysable groups, the test substance cannot undergo pH-dependent hydrolysis in the stomach. As it does not bear resemblance to fatty acids, uptake via micelles with bile acids is unlikely.
Slight to marginal skin permeability can be assumed based on a model calculation (Fitzpatrick, et al., 2004).
Metabolism
Single oral application of the test item to male and female rats did not provoke any effect. Oral administration to Wistar rats at doses of 300, 1000 and 3000 mg/kg/day, for 28 days resulted in slightly increased liver weight. Based on the results of this study, 300 and 1000 mg/kg/day, respectively, were considered to be the no observed- adverse-effect-levels (NOAEL) for male and female animals. In the course of a reproduction / developmental toxicity screening study, no such effects were observed. The NOAEL for the F0 and F1 generation is considered to be 1000 mg/kg bw. No indication of chemical reactivity and only very limited absorption was observed in any study, including acute studies, irritation, sensitization and genotoxicity in vitro as well as the above described subacute and OECD 421 study.
In the case of uptake, potential metabolism might involve hydroxylation of keto and methyl -groups and enzymatic cleavage of azo bonds. The test substance is not expected to accumulate in the body.
Excretion
The substance is expected to be excreted unchanged via the feces. In case of gastrointestinal uptake and metabolism through hydroxylation and phase-II metabolism it is expected that the test substance might be excreted predominantly via the urine. Overall, the test substance is not expected to accumulate in the body.
Used references:
Fitzpatrick, D., et al. (2004). "Modelling skin permeability in risk assessment-the future." Chemosphere 55 (10): 1309-14.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.